Individuals Discontinuing Weight-Loss Injections Put On Pounds Four Times Faster Than Dieters

Fresh analysis suggests that people who discontinue popular slimming jabs like semaglutide or tirzepatide tend to recover lost weight far faster than those who halt traditional lifestyle regimens.

Findings released in a leading health publication points out that while obese individuals can lose substantial amounts of their body weight while on the medication, the weight returns at an average rate of 0.8 kg per month once they quit.

"People purchasing these medications should be cognizant of the risk of quick weight regain when the medication is stopped," stated expert Dr. Susan Jebb.

That rate of regain means a return to original weight within about 18 months.

Comparing Approaches

The study, which looked at 37 of studies involving thousands of patients, compared the effects of the injectable medications with older methods.

Scientists emphasize that people who lose weight through lifestyle changes alone generally experience a slower weight regain—approximately 0.1 kg a month—post-intervention.

Understanding the Quick Regain

Doctors believe the way of the injections is key to understanding the amplified rebound.

The injections mimic a body's own chemical called glucagon-like peptide-1, which helps regulate appetite.

"Artificially providing the hormone levels far above than normal could lead to the body to generate a reduced amount of its endogenous GLP-1, and could diminish sensitivity to its effects," said Dr. Adam Collins, a nutrition specialist.

"Stopping of this medication results in hunger is uncontrolled, making excessive eating much more probable."

A Chronic Condition?

The NHS recommend the injections for people with obesity-related medical conditions, accompanied by prescribed lifestyle changes.

Many experts argue that, given the high risk of weight regain, the therapy is often life-long.

This opinion is supported by drug manufacturers, who note that the results "highlight the persistent character of excess weight," comparing it to managing conditions like diabetes.

User Experiences

Users who have discontinued the medication describe a intense resurgence of hunger.

"It felt as if a trigger flipping and I was suddenly starving," recalled a patient.

The struggle is worsened if patients have not established permanent lifestyle or habit modifications during therapy.

Widespread Adoption

Recent estimates show that millions of adults in the UK have tried these injections in the past year, with desire continuing to grow.

• Use is greater among females than males.
• The 40s and 50s demographic shows the greatest level of interest.
• Many access the medications through private prescriptions rather than public health services.

Ultimately, researchers caution that while these medications are effective tools for shedding pounds, they are not a permanent solution and maintained weight loss likely depends on integrated behavioural management.